Kelly Shi
Stock Analyst at Jefferies
(1.57)
# 3,070
Out of 4,876 analysts
30
Total ratings
37.04%
Success rate
-3.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Initiates: Buy | $105 | $99.49 | +5.54% | 1 | May 13, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $20.60 | +113.59% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $4.15 | +261.45% | 1 | Apr 10, 2025 | |
| OPT Opthea | Downgrades: Underperform | $1 | $3.41 | -70.67% | 1 | Mar 25, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $22.97 | +126.38% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $4.84 | +189.26% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $13.20 | +43.94% | 2 | Sep 11, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $174 → $196 | $172.14 | +13.86% | 2 | Aug 13, 2024 | |
| ARTV Artiva Biotherapeutics | Initiates: Buy | $21 | $1.47 | +1,328.57% | 1 | Aug 13, 2024 | |
| SNDX Syndax Pharmaceuticals | Initiates: Buy | $37 | $9.03 | +309.97% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $0.67 | +797.26% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $46 | $49.84 | -7.70% | 3 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $68.37 | +18.47% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $22.91 | +52.77% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.57 | +2,192.99% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $47.52 | -66.33% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $44.12 | -9.34% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.60 | +334.78% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.70 | +196.30% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $0.63 | +4,215.86% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $15.09 | +244.60% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $1.00 | +2,600.00% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.92 | +1,618.75% | 1 | Mar 8, 2021 |
Insmed
May 13, 2025
Initiates: Buy
Price Target: $105
Current: $99.49
Upside: +5.54%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $20.60
Upside: +113.59%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $4.15
Upside: +261.45%
Opthea
Mar 25, 2025
Downgrades: Underperform
Price Target: $1
Current: $3.41
Upside: -70.67%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $22.97
Upside: +126.38%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.84
Upside: +189.26%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $13.20
Upside: +43.94%
Ascendis Pharma
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $172.14
Upside: +13.86%
Artiva Biotherapeutics
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $1.47
Upside: +1,328.57%
Syndax Pharmaceuticals
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $9.03
Upside: +309.97%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $0.67
Upside: +797.26%
May 20, 2024
Maintains: Buy
Price Target: $35 → $46
Current: $49.84
Upside: -7.70%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $68.37
Upside: +18.47%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $22.91
Upside: +52.77%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $1.57
Upside: +2,192.99%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $47.52
Upside: -66.33%
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $44.12
Upside: -9.34%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $4.60
Upside: +334.78%
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $2.70
Upside: +196.30%
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $0.63
Upside: +4,215.86%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $15.09
Upside: +244.60%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $1.00
Upside: +2,600.00%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $1.92
Upside: +1,618.75%